Diffuse Lewy body disease (BDTL) also known as diffuse Lewy body disease variant, or dementia with Lewy bodies. In contrast to Parkinson's disease, which is a variant of the disease stem Lewy bodies, characterized more BDTL common degenerative process, involving not only the substantia nigra, but also other parts of the brain, especially the cortex (especially the anterior cingulate and medial temporal lobe), and basal nucleus of Meynert also. In some patients with pathologic study of the cerebral cortex in addition to Lewy bodies are detected changes characteristic of Alzheimer's disease (Eldepryl side effects).Diffuse Lewy body disease usually develops in older individuals and is manifested in two major syndromes - Parkinson's disease and dementia: - Parkinson's disease is often akinetic-rigid nature, it is resistant to the drug Selegiline and is sometimes accompanied by focal dystonia or myoclonus, but in some cases, has all the characteristics, characteristic of Parkinson's disease.Dementia has been mixed, cortical-subcortical, and character associated with involvement in the process not only frontostriarnyh systems, but also the parietal-temporal cortex, the limbic system, cholinergic basal nucleus Meynert.There are three main options for developing the disease during Eldepryl uses: initially manifested increasing cognitive defect, which subsequently can be attached signs of parkinsonism. In many such cases, dementia is a clinical syndrome leading to lifelong disease, symptoms of Parkinson's disease when expressed in minimal or absent. The differential diagnosis of Alzheimer's disease may present significant difficulties for Purchase Eldepryl.